BBV154

· Bharat Biotech International Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BBV154, covering 2022-08-31 to 2022-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose [Phase 3]